Cash Flow Statement

Altimmune (ALT) EBIT Margin Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -40,178.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 530.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -1,211.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 6,993.00
10 Altimmune 379.61 Mn 379.61 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -2.23 Mn
Sep 30, 2025 82.04 Mn
Jun 30, 2025 -20.35 Mn
Mar 31, 2025 -37.54 Mn
Dec 31, 2024 -49.66 Mn
Sep 30, 2024 -47.43 Mn
Jun 30, 2024 -51.68 Mn
Mar 31, 2024 -53.41 Mn
Dec 31, 2023 -9.04 Mn
Sep 30, 2023 -560,282.00
Jun 30, 2023 -29.97 Mn
Mar 31, 2023 -10.33 Mn
Dec 31, 2022 -8.81 Mn
Sep 30, 2022 -123.58 Mn
Jun 30, 2022 -25.47 Mn
Mar 31, 2022 -6.09 Mn
Dec 31, 2021 32,446.00
Sep 30, 2021 -2.09 Mn
Jun 30, 2021 -1.79 Mn
Mar 31, 2021 -155,062.00
Dec 31, 2020 24,697.00
Sep 30, 2020 5,036.00
Jun 30, 2020 -25,983.00
Mar 31, 2020 117,763.00
Dec 31, 2019 -25,643.00
Sep 30, 2019 9.52 Mn
Jun 30, 2019 5,433.00
Mar 31, 2019 4,595.00
Dec 31, 2018 -98,212.00
Sep 30, 2018 -1,055.00
Jun 30, 2018 -5,396.00
Mar 31, 2018 -23,919.00
Dec 31, 2017 -56,813.00
Sep 30, 2017 -25,887.00
Jun 30, 2017 -10,006.00
Mar 31, 2017 -144,367.00
Dec 31, 2016 -35,377.00
Sep 30, 2016 -9.69 Mn
Jun 30, 2016 -23,822.00
Mar 31, 2016 -10,789.00
Dec 31, 2015 -5,053.00
Sep 30, 2015 -11,676.00
Jun 30, 2015 -14,784.00
Mar 31, 2015 4,229.00
Dec 31, 2014 -12,630.00
Sep 30, 2014 -35,774.00
Jun 30, 2014 1,596.00
Mar 31, 2014 746.00
Dec 31, 2013 -3,298.00
Sep 30, 2013 -3,783.00
Jun 30, 2013 8,135.00